Effectiveness of Human Papillomavirus Vaccination on Prevalence of Vaccine Genotypes in Young Sexually Active Women in France

Background. Effectiveness of human papillomavirus (HPV) vaccines in the context of both guidelines, which recommend vaccination at 14 years and modest vaccine coverage, is poorly documented. Methods. Residual specimens from females aged

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of infectious diseases 2017-03, Vol.215 (5), p.757-763
Hauptverfasser:	Heard, Isabelle, Tondeur, Laura, Arowas, Laurence, Demazoin, Marie, Falguières, Michaël, Du Chatelet, Isabelle Parent
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Case-Control Studies Chlamydia trachomatis - isolation & purification DNA, Viral - isolation & purification Female France Genotype Humans Incidence Multivariate Analysis Papillomaviridae - genetics Papillomaviridae - isolation & purification Papillomavirus Infections - epidemiology Papillomavirus Infections - prevention & control Papillomavirus Vaccines - therapeutic use Sexual Behavior - drug effects Uterine Cervical Neoplasms - epidemiology Uterine Cervical Neoplasms - prevention & control Uterine Cervical Neoplasms - virology VIRUSES Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Background. Effectiveness of human papillomavirus (HPV) vaccines in the context of both guidelines, which recommend vaccination at 14 years and modest vaccine coverage, is poorly documented. Methods. Residual specimens from females aged
ISSN:	0022-1899 1537-6613
DOI:	10.1093/infdis/jiw639